SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

81,592.45 -318.56
( -0.39%)

Global Indices

Nasdaq

52,349.65 31.56
(0.06%)

Dow Jones

7,578.06 -35.34
(-0.46%)

Hang Seng

61,109.24 289.88
(0.48%)

Nikkei 225

10,906.25 43.16
(0.40%)

Forex

USD-INR

93.72 0.15
(0.16%)

EUR-INR

104.27 -0.51
(-0.49%)

GBP-INR

124.72 -0.66
(-0.52%)

JPY-INR

0.59 0.00
(-0.43%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Aprameya Engineering Ltd

Industry : Healthcare

BSE Code

ISIN Demat

Book Value()

77825

INE0LQG01010

36.4170693

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

APRAMEYA

51.62

260.47

EPS(TTM)

Face Value()

Div & Yield %

2.65

Back

Symbiotec Pharmalab consolidated net profit rises 169.15% in the September 2026 quarter

Nov 06,2026

Net profit of Symbiotec Pharmalab rose 169.15% to Rs 51.73 crore in the quarter ended September 2026 as against Rs 19.22 crore during the previous quarter ended September 2025. Sales rose 43.17% to Rs 279.93 crore in the quarter ended September 2026 as against Rs 195.52 crore during the previous quarter ended September 2025.

Particulars	Quarter Ended
	Sep. 2026	Sep. 2025	% Var.
Sales	279.93	195.52	43
OPM %	32.69	25.72	-
PBDT	85.92	44.06	95
PBT	64.04	33.47	91
NP	51.73	19.22	169

81,592.45 -318.56 ( -0.39%)

52,349.65 31.56 (0.06%)

7,578.06 -35.34 (-0.46%)

61,109.24 289.88 (0.48%)

10,906.25 43.16 (0.40%)

93.72 0.15 (0.16%)

104.27 -0.51 (-0.49%)

124.72 -0.66 (-0.52%)

0.59 0.00 (-0.43%)